top of page
Thinking Business
a blog by Chris Barrow

Oracle's $80 Billion share price drop, the fragility of the AI marketplace and what it means to Dental Practice Owners

What a sudden loss of confidence in big tech tells us about risk, resilience and decision-making in dental practice ownership
What a sudden loss of confidence in big tech tells us about risk, resilience and decision-making in dental practice ownership

There's no bigger fan of AI than me - but.......


Oracle’s $80 billion drop in market value yesterday (yikes) has sent shockwaves through the tech world.


This sharp decline followed a small shortfall in their earnings forecast, revealing just how sensitive the AI marketplace remains. The event highlights the risks companies face when heavily investing in AI-driven business systems and serves as a cautionary tale for those navigating this rapidly evolving landscape.


The AI market is still in its early stages, and expectations are sky-high. Investors expect rapid growth and consistent performance, but even small missteps can lead to sharp corrections. Oracle’s drop shows that the AI sector is not immune to volatility, and companies must manage expectations carefully.


2025 was the year in which AI impacted our daily lives - we are using ChatGPT, Gemini 3, Perplexity, Claude and host of other systems, both visible and behind the scenes, to automate what used to be hard labour.


AI technologies promise to transform industries, from healthcare to finance to manufacturing. However, the path to widespread adoption is complex and uncertain. Many AI projects are still in beta or pilot phases.


  • High expectations: Investors and customers expect AI solutions to deliver immediate, measurable improvements. Sometimes even miracles.

  • Unproven business models: Many AI-driven products are new, with unclear revenue streams.

  • Rapid innovation cycles: AI technology evolves quickly, making it hard for companies to maintain a competitive edge.

  • Regulatory and ethical concerns: These add layers of uncertainty and risk.


Many clients are asking me "which PMS, which CRM, which bookkeeping, which note-taking, which project management, which reception, which scanner and supporting software?" - it's getting bewildering and impossible to know which horse to back.


Any dental business investing heavily in AI-driven systems should proceed - but with caution. Beta testing and pilot programmes are essential to understand how AI tools perform in real-world settings. Here are some practical tips:


  • Start small: Test AI applications in limited areas before full-scale deployment.

  • Set realistic goals: Avoid overpromising on AI capabilities to team and patients.

  • Monitor performance closely: Use clear metrics to evaluate AI impact.

  • Prepare for setbacks: Have contingency plans if AI projects underperform.

  • Stay informed: Keep up with AI advancements and regulatory changes.


The Oracle case shows that no company is guaranteed to succeed in the AI race. Market leaders today might face challenges tomorrow, while smaller players could emerge as winners. Factors influencing success include:


  • Ability to innovate and adapt quickly

  • Effective integration of AI into existing business models

  • Customer trust and satisfaction

  • Regulatory compliance and ethical AI use


That applies just as much to you and your business, me and mine, as it does to the tech giants.


I'm not saying "don't", quite the opposite; but I am saying "be careful".


 
 
 

Comments


bottom of page